Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cardiac diseases: when less is more

30.03.2017

Which patient will benefit most from a platelet inhibitor after a heart operation? The Department of Cardiology of Inselspital, Bern University Hospital, can answer this question with a new test, which has been published in "The Lancet".

Spending less time in hospital, having to take less medication after surgery – both are concerns shared by most patients. In a study published this month, the Department of Cardiology of Inselspital addressed this concern.


PRECISE-DAPT Score

Department of Cardiology, Inselspital, Bern University Hospital

In accordance with the principle of weighing benefits and risks, upon which all medical treatments are based, it took an in-depth look at medicinal after-care from the patients’ perspective.

After surgery on the coronary arteries, patients routinely receive platelet-inhibiting drugs for approx. one year. This is intended to prevent heart attacks. These drugs, however, may cause bleeding complications in some patients. Until now, doctors have been unable to find out how high the risk of bleeding was for each person.

Personalised after-care thanks to a simple test

In a multicentric study under the direction of Prof. Marco Valgimigli, from the Department of Cardiology of Inselspital, cardiologists have now developed a simple five-part test: This identifies the individual bleeding risk based on the factors of age, kidney function, haemoglobin level, number of white platelets and previous spontaneous bleedings.

In the case of a high risk, the drugs are prescribed for only approx. three months – because this period of time the patient benefits from the protective effect against heart attack, but has no serious side-effects.

People without an increased risk of bleeding, on the other hand, can take the medicinal coronary prophylaxis for longer because, with good protection, they do not have to worry about bleedings.

Contact:

Prof. Dr. med. Marco Valgimigli, Senior Physician, Department of Cardiology, Inselspital, Bern University Hospital, +41 31 632 47 14, marco.valgimigli@insel.ch.

Weitere Informationen:

http://thelancet.com/journals/lancet/article/PIIS0140-6736(17)30397-5/fulltext
http://www.precisedaptscore.com

Monika Kugemann | Universitätsspital Bern

Further reports about: cardiology coronary arteries heart attacks kidney function

More articles from Health and Medicine:

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

nachricht Breakthrough in understanding how deadly pneumococcus avoids immune defenses
13.11.2018 | University of Liverpool

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>